Kaloba

Pelargonium sidoides root extract, the active ingredient in Kaloba, is a herbal medicine presented as a liquid oral solution for oral use. It is used to help relieve symptoms of acute bronchitis and cough in adults and children.

GNH USA supplies Kaloba as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaloba, a herbal medicine for respiratory tract infections, is used in the following conditions:

Acute bronchitis: helps reduce cough frequency and supports airway comfort during recovery. Cough: alleviates persistent cough associated with upper respiratory infections. Upper respiratory tract infection: provides symptomatic relief of throat irritation and mucus production.

Kaloba is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Gastrointestinal upset, such as mild nausea or stomach discomfort. - Diarrhea or loose stools. - Bitter or unpleasant taste. - Headache. - Skin rash or mild itching. - Dizziness.

Serious or Rare Side Effects: - Anaphylactic reaction or severe allergic response. - Stevens‑Johnson syndrome or other severe skin eruptions. - Hepatotoxicity presenting as jaundice or abnormal liver enzymes.

When using Kaloba, consider the following precautions: - Children under 2 years: not recommended without medical advice. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: safety not established; seek professional guidance. - Known hypersensitivity to Pelargonium species: avoid product. - Concomitant use with immunosuppressive therapy: monitor clinical response. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Kaloba may interact with other medicines; consider these interaction categories.

Major Interactions (Avoid): - Concurrent use with other herbal cough preparations containing similar extracts, due to additive effects. - Combination with immunosuppressive agents, which may diminish therapeutic response.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): potential for increased bleeding risk. - Antidiabetic drugs: possible enhancement of hypoglycaemic effect. - Antihypertensive agents: monitor blood pressure for additive lowering.